(Q33364468)

26 July 2017

The safety of interferon-gamma-1b therapy for invasive fungal infections after hematopoietic stem cell transplantation (English)

1 reference

invasive fungal infections

26 July 2017

1 reference

inferred from title

author

Dimitrios P Kontoyiannis

4

object named as

Dimitrios P Kontoyiannis

1 reference

26 July 2017

7

Richard E Champlin

1 reference

26 July 2017

Amar Safdar

1

1 reference

26 July 2017

Gilhen Rodriguez

2

1 reference

26 July 2017

Norio Ohmagari

3

1 reference

26 July 2017

Kenneth V Rolston

5

1 reference

26 July 2017

Issam I Raad

6

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 February 2005

1 reference

26 July 2017

9

1 reference

inferred from page(s)

published in

Cancer

1 reference

26 July 2017

103

1 reference

26 July 2017

4

1 reference

26 July 2017

731-739

1 reference

Therapeutic outcome in invasive aspergillosis

26 July 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20883

The role of interleukin-12 in preserving the graft-versus-leukemia effect of allogeneic CD8 T cells independently of GVHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20883

Infections in bone marrow transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20883

Impact of high-dose granulocyte transfusions in patients with cancer with candidemia: retrospective case-control analysis of 491 episodes of Candida species bloodstream infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20883

7 January 2021

Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20883

7 January 2021

The spectrum of non-Candida fungal infections following bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20883

7 January 2021

Epidemiology ofAspergillusInfections in a Large Cohort of Patients Undergoing Bone Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20883

7 January 2021

Invasive aspergillosis in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20883

7 January 2021

Aspergillosis case-fatality rate: systematic review of the literature

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20883

7 January 2021

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20883

7 January 2021

Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. Observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20883

7 January 2021

Regulation by granulocyte-macrophage colony-stimulating factor and/or steroids given in vivo of proinflammatory cytokine and chemokine production by bronchoalveolar macrophages in response to Aspergillus conidia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20883

7 January 2021

A TH1-TH2-like switch in candidiasis: new perspectives for therapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20883

7 January 2021

Defective antifungal T-helper 1 (TH1) immunity in a murine model of allogeneic T-cell-depleted bone marrow transplantation and its restoration by treatment with TH2 cytokine antagonists.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20883

7 January 2021

Hemopoietic stem cell transplantation using mouse bone marrow and spleen cells fractionated by lectins

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20883

7 January 2021

Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20883

7 January 2021

Basiliximab is well tolerated and effective in the treatment of steroid-refractory acute graft-versus-host disease after allogeneic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20883

7 January 2021

Tumor necrosis factor-alpha blockade for the treatment of acute GVHD.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20883

7 January 2021

IFN-gamma-mediated prevention of graft-versus-host disease: pharmacodynamic studies and influence on proliferative capacity of chimeric spleen cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20883

7 January 2021

Interleukin 2 prevents graft-versus-host disease while preserving the graft-versus-leukemia effect of allogeneic T cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20883

7 January 2021

Donor-derived interferon gamma is required for inhibition of acute graft-versus-host disease by interleukin 12.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20883

7 January 2021

Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20883

7 January 2021

Interleukin-18 regulates acute graft-versus-host disease by enhancing Fas-mediated donor T cell apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20883

7 January 2021

Decreased graft-versus-host disease after haplotype mismatched bone marrow allografts in miniature swine following interleukin-2 treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20883

7 January 2021

Diagnosis of invasive septate mold infections. A correlation of microbiological culture and histologic or cytologic examination

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20883

7 January 2021

Tacrolimus does not abrogate the increased risk of acute graft-versus-host disease after unrelated-donor marrow transplantation with allelic mismatching at HLA-DRB1 and HLA-DQB1.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20883

7 January 2021

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20883

7 January 2021

Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20883

7 January 2021

Clinical significance of non-Candida fungal blood isolation in patients undergoing high-risk allogeneic hematopoietic stem cell transplantation (1993-2001).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20883

7 January 2021

Persistence of host dendritic cells after transplantation is associated with graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20883

7 January 2021

Cytokine and chemokine profiles in autologous graft-versus-host disease (GVHD): interleukin 10 and interferon gamma may be critical mediators for the development of autologous GVHD.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20883

7 January 2021

The immunopathophysiology of acute graft-versus-host-disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20883

7 January 2021

Graft-versus-host disease and the Th1/Th2 paradigm

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20883

7 January 2021

Th1 and Th2 mediate acute graft-versus-host disease, each with distinct end-organ targets

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20883

7 January 2021

Interferon gamma plays a critical role in induced cell death of effector T cell: a possible third mechanism of self-tolerance

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20883

7 January 2021

The Th1/Th2 paradigm and the allograft response

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20883

7 January 2021

The potential role of NK cells in the separation of graft-versus-tumor effects from graft-versus-host disease after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20883

7 January 2021

Identifiers

DOI

10.1002/CNCR.20883

1 reference

26 July 2017

1 reference